Research reveals therapeutic potential of novel compound in inhibiting oncogene translation

FHS
July 24, 2023
9:09 am

Cutting-edge research at the Luxembourg Institute of Health reveals the ground-breaking therapeutic potential of the compound FL3 in inhibiting oncogene translation and rewiring cancer cell metabolism, opening up new therapeutic opportunities for leukemia patients.

Abivax announces the release of its 2023 half-year financial report – Biotech Investments

EQS-News: ABIVAX / Key word(s): Half Year Report Abivax announces the release of its 2023 half-year financial report 29.09.2023 / 18:00 CET/CEST The issuer is solely

September 30, 2023

Talkiatry and ERC Pathlight Partner to Bridge Gaps in Eating Disorder and Mood Disorder Care

What You Should Know: – Talkiatry, a provider of virtual psychiatric care, and Eating Recovery Center (ERC) Pathlight, a renowned provider of specialized eating disorder

December 19, 2024

What could fix cancer clinical trials’ longstanding diversity problem?

There’s a diversity problem in cancer clinical trials, and few know this better than Stephanie Walker. When she was diagnosed with stage 4 metastatic breast

September 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.